Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide

被引:22
作者
Fathizadeh, Hadis [1 ]
Saffari, Mahmood [1 ]
Esmaeili, Davoud [2 ,3 ,4 ]
Moniri, Rezvan [1 ,5 ]
Salimian, Morteza [5 ]
机构
[1] Kashan Univ Med Sci, Fac Med, Dept Microbiol & Immunol, Kashan, Iran
[2] Baqiyatallah Univ Med Sci, Dept Microbiol, Syst Biol & Poisonings Inst, Tehran, Iran
[3] Baqiyatallah Univ Med Sci, Appl Microbiol Res Ctr, Tehran, Iran
[4] Baqiyatallah Univ Med Sci, Appl Virol Res Ctr, Tehran, Iran
[5] Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran
关键词
Antibacterial activity; Bacteriocins; Colicin E1; Enterocin A; Fusion peptide; ANTIMICROBIAL PEPTIDES; SYNERGISTIC INTERACTION; FAECIUM P13; BACTERIOCIN; EXPRESSION; CLONING; PURIFICATION; IMMUNITY;
D O I
10.22038/ijbms.2020.47826.11004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): Bacterial resistance to most common antibiotics is a harbinger of the requirement to find novel anti-infective, antimicrobials agents, and increase innovative strategies to struggle them. Numerous bacteria produce small peptides with antimicrobial activities called bacteriocin. This study aimed to investigate the antibacterial properties of the fusion protein of Enterocin A and Colicin E1 modified against pathogens. Materials and Methods: Analysis of recombinant bacteriocin Enterocin A and Colicin E1 (ent A-col E1) was performed to assay the stability and antibacterial activity of this fusion protein. The pET-22b vector was employed to express the coding sequence of the ent A-col E1 peptide in Escherichia coli BL21 (DE3). Minimum inhibitory concentration (MIC), disk diffusion, and time-kill tests were performed to evaluate the antibacterial activity of the ent A-col E1 against Pseudomonas aeruginosa (ATCC 9027), Escherichia coli (ATCC 10536), Enterococcus faecalis (ATCC 29212), and Staphylococcus aureus (ATCC 33591). Results: The suggested recombinant peptide had good antibacterial activity against both Gram-negative and Gram-positive pathogens. It has also good stability at various temperatures, pH levels, and salt concentrations. Conclusion: Because bacteriocins are harmless compounds, they can be recommended as therapeutic or preventive supplements to control pathogens. According to the obtained results, the ent A-col E1 peptide can serve as an efficient antibacterial compound to treat or prevent bacterial infections.
引用
收藏
页码:1471 / 1479
页数:9
相关论文
共 47 条
[1]   Cloning, overexpression, purification of bacteriocin enterocin-B and structural analysis, interaction determination of enterocin-A, B against pathogenic bacteria and human cancer cells [J].
Ankaiah, Dasari ;
Palanichamy, Esakkiraj ;
Antonyraj, Christian Bharathi ;
Ayyanna, Repally ;
Perumal, Venkatesh ;
Ahamed, Syed Ibrahim Basheer ;
Arul, Venkatesan .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 116 :502-512
[2]   Probiotic characterization of Enterococcus faecium por1: Cloning, over expression of Enterocin-A and evaluation of antibacterial, anti-cancer properties [J].
Ankaiah, Dasari ;
Palanichamy, Esakkiraj ;
Perumal, Venkatesh ;
Ayyanna, Repally ;
Venkatesan, Arul .
JOURNAL OF FUNCTIONAL FOODS, 2017, 38 :280-292
[3]   Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecalis BFE 1071 [J].
Balla, E ;
Dicks, LMT ;
Du Toit, M ;
van der Merwe, MJ ;
Holzapfel, WH .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (04) :1298-1304
[4]   Use of the Yeast Pichia pastoris as an Expression Host for Secretion of Enterocin L50, a Leaderless Two-Peptide (L50A and L50B) Bacteriocin from Enterococcus faecium L50 [J].
Basanta, Antonio ;
Gomez-Sala, Beatriz ;
Sanchez, Jorge ;
Diep, Dzung B. ;
Herranz, Carmen ;
Hernandez, Pablo E. ;
Cintas, Luis M. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2010, 76 (10) :3314-3324
[5]   Novel antilisterial bacteriocin licheniocin 50.2 from Bacillus licheniformis VPS50.2 isolated from soil sample [J].
Beric, T. ;
Stankovic, S. ;
Draganic, V. ;
Kojic, M. ;
Lozo, J. ;
Fira, D. .
JOURNAL OF APPLIED MICROBIOLOGY, 2014, 116 (03) :502-510
[6]   Production of disulfide-bonded proteins in Escherichia coli [J].
Berkmen, Mehmet .
PROTEIN EXPRESSION AND PURIFICATION, 2012, 82 (01) :240-251
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Lipid II as a target for antibiotics [J].
Breukink, E ;
de Kruijff, B .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :321-332
[9]   Structural Insights into and Activity Analysis of the Antimicrobial Peptide Myxinidin [J].
Cantisani, Marco ;
Finamore, Emiliana ;
Mignogna, Eleonora ;
Falanga, Annarita ;
Nicoletti, Giovanni Francesco ;
Pedone, Carlo ;
Morelli, Giancarlo ;
Leone, Marilisa ;
Galdiero, Massimiliano ;
Galdiero, Stefania .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :5280-5290
[10]   Mechanisms of colicin binding and transport through outer membrane porins [J].
Cao, Z ;
Klebba, PE .
BIOCHIMIE, 2002, 84 (5-6) :399-412